Sars-CoV2
Showing 51 - 75 of 123
Intensive Care Associated Complications and Outcome of Acute
Recruiting
- COVID
- +2 more
- Study Arm
-
Bern, SwitzerlandInselspital Bern
Jul 8, 2021
Immune Response Against COVID-19 Among Hospital Staff
Active, not recruiting
- Sars-CoV2
- Clinical interview
- +2 more
-
Clamart, FranceHôpital d'Instuction des Armées Percy
Jul 6, 2021
COVID, Sars-CoV2, ARDS, Human Trial (Tadalafil Pill)
Withdrawn
- COVID
- +2 more
- Tadalafil Pill
- (no location specified)
Jun 30, 2021
COVID, ARDS, Human, Ards Trial in Milano (IC14, a mAb against CD14)
No longer available
- COVID
- +3 more
- IC14, a monoclonal antibody against CD14
-
Milano, ItalyIRCCS San Raffaele Scientific Institute, Vita-Salute San Raffael
Jun 15, 2021
COVID-19 on Pediatric Dental Practice During First, Second And
Recruiting
- SARS-CoV2
-
Cairo, EgyptFaculty of Oral and Dental Medicine, Cairo University
Jun 11, 2021
Sars-CoV2, Covid-19, Pregnancy Complications Trial in Sweden (biological samples, questionnaires and interviews)
Recruiting
- Sars-CoV2
- +5 more
- biological samples, questionnaires and interviews
-
Falun, Dalarna, Sweden
- +26 more
Jun 3, 2021
COVID 19, Coronavirus, Diabetes, Type 2 Trial in Be'er Ya'aqov, Petah tikva (Linagliptin 5 MG)
Terminated
- COVID 19
- +14 more
- Linagliptin 5 MG
-
Be'er Ya'aqov, Israel
- +2 more
May 28, 2021
Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Respiratory Failure, Sars-CoV2 Trial in San Antonio (Rapamycin,
Withdrawn
- Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
- +2 more
- Rapamycin
- Placebo
-
San Antonio, Texas
- +1 more
May 27, 2021
Clinical Features of Severe Patients With COVID-19
Completed
- SARS-CoV2
- The demographic, clinical, laboratory, and instrumental data
-
Moscow, Russian FederationFederal Research Clinical Center of Federal Medical & Biological
May 19, 2021
Post-traumatic Stress of Patients Hospitalized in Intensive Care
Active, not recruiting
- Intensive Care Unit
- SARS-CoV2
-
Paris, Ile De France, FranceGH Pitié Salpêtrière - Charles Foix
May 14, 2021
COVID, Severe Acute Respiratory Syndrome, Sars-CoV2 Trial in Canada, Turkey, United States (LSALT peptide, Placebo)
Active, not recruiting
- COVID
- +3 more
- LSALT peptide
- Placebo
-
San Diego, California
- +6 more
May 5, 2021
Respiratory Distress Syndrome, Adult, Sars-CoV2 Trial in Baltimore (Hypothermia, Neuromuscular Blocking Agents, Standard of
Withdrawn
- Respiratory Distress Syndrome, Adult
- Sars-CoV2
- Hypothermia
- +2 more
-
Baltimore, MarylandUniversity of Maryland Medical Center
Apr 27, 2021
Echocardiography in Critically-ill COVID-19 Pneumonia
Enrolling by invitation
- COVID
- Sars-CoV2
-
Boulogne-Billancourt, Hauts De Seine, FranceUniversity Hospital Ambroise Pare
Apr 28, 2021
Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 Trial in Sao Paulo (Janus Kinase Inhibitor (ruxolitinib), Placebo)
Terminated
- Severe Acute Respiratory Syndrome Coronavirus 2
- SARS-CoV2
- Janus Kinase Inhibitor (ruxolitinib)
- Placebo
-
Sao Paulo, BrazilHospital das Clínicas
Apr 5, 2021
COVID, Covid-19, Corona Virus Infection Trial in Ventura (ResCure™)
Withdrawn
- COVID
- +6 more
- ResCure™
-
Ventura, CaliforniaProgenaBiome
Apr 6, 2021
SARS-CoV2, COVID-19 Trial in Ankara, Istanbul (Ribavirin Capsules, Favipiravir)
Not yet recruiting
- SARS-CoV2
- COVID-19
- Ribavirin Capsules
- Favipiravir
-
Ankara, Cebeci, Turkey
- +3 more
Apr 1, 2021
Immune Cells Phenotypes During COVID-19
Recruiting
- Sars-CoV2
- +4 more
- Peripheral blood samples
-
Marseille, France
- +1 more
Mar 24, 2021
Thrombomodulin-modified Thrombin Generation Assay in Critical
Completed
- Disseminated Intravascular Coagulation
- +5 more
- Thrombin Generation Assay (TGA)
- Thrombomodulin Modified Thrombin Generation Assay (TGA-TM)
-
Vienna, AustriaMedical University Vienna
Mar 22, 2021
Sars-CoV2 Trial in Timisoara, Reus, Tarragona (Recombinant human plasma gelsolin (Rhu-pGSN), Placebo)
Active, not recruiting
- Sars-CoV2
- Recombinant human plasma gelsolin (Rhu-pGSN)
- Placebo
-
Timişoara, Romania
- +2 more
Mar 12, 2021
Covid-19, Sars-CoV2, Pneumonia Trial in Colombia, United States (Low dose radiation 35 cGy, High dose radiation 100 cGy)
Recruiting
- Covid-19
- +2 more
- Low dose radiation 35 cGy
- High dose radiation 100 cGy
-
Boca Raton, Florida
- +7 more
Mar 11, 2021
Sars-CoV2, Symptomatic Condition, Covid-19 Trial in Lahore (Hydroxychloroquine Sulfate Regular dose, Hydroxychloroquine Sulfate
Terminated
- Sars-CoV2
- +2 more
- Hydroxychloroquine Sulfate Regular dose
- +3 more
-
Lahore, Punjab, Pakistan
- +3 more
Mar 8, 2021
SARS-COV-2 Serological Profile ofArmy Training Hospital Staff
Completed
- Sars-CoV2
- Anti-SARS-CoV2 Serology
- Questionnaire
-
Toulon, France
- +1 more
Mar 8, 2021